Head-to-head · WeighScore
FuturHealth vs TeleCareSpot
The verdict
TeleCareSpot takes it — 67.7/100 to 65.6/100.
TeleCareSpot grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FuturHealth | TeleCareSpot |
|---|---|---|
| WeighScore | 65.6/100 | 67.7/100 |
| Grade | C | C |
| Scorecard rank | #215 | #160 |
| Semaglutide | $199/mo (compounded) | $299/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $399/mo |
| Coverage | Coverage not published | 48 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #215 · C
Strengths
- LegitScript Certified and HITRUST Certified
- Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
- Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
- Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths
Where it loses points
- Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
- BBB complaints describe recurring charges without medication received — confirm cancellation flow first
- Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
- Pricing not shown until after the qualification questionnaire or portal login
- Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Graded #160 · C
Strengths
- Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
- Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
- Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
- DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
- Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans
Where it loses points
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Not available in Alaska, Mississippi, or New Jersey
- The compounding pharmacy partner is not named
- A separate weight-loss consultation fee applies (credited toward your medication package if approved)
- Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.